Growth Metrics

Omeros (OMER) Other Non-Current Assets (2010 - 2026)

Omeros recorded quarterly Other Non-Current Assets of $1.1 million in Q1 2026, little changed quarter-over-quarter from $1.1 million in Q4 2025, and little changed year-over-year from $1.1 million in Q1 2025.

Omeros' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed 0.0% YoY), while the FY2025 annual figure was $1.1 million, changed 0.0% from the prior year.
  • Other Non-Current Assets came in at $1.1 million for Q1 2026 at Omeros, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.1 million in Q1 2024 to a low of $1.1 million in Q1 2022.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2022 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets jumped 414.15% in 2022 and fell 4.18% in 2025, its largest moves.
  • Omeros' Other Non-Current Assets stood at $1.1 million in 2022, then changed by 0.0% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then changed by 0.0% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.1 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 1.05 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.05 Mn
Dec 31, 2025 1.05 Mn
Sep 30, 2025 1.05 Mn
Jun 30, 2025 1.05 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 1.10 Mn
Dec 31, 2023 1.05 Mn
Sep 30, 2023 1.05 Mn
Jun 30, 2023 1.05 Mn
Mar 31, 2023 1.05 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 1.05 Mn
Jun 30, 2022 1.05 Mn
Mar 31, 2022 1.05 Mn
Dec 31, 2021 1.05 Mn
Sep 30, 2021 1.05 Mn
Jun 30, 2021 205,000.00
Mar 31, 2021 1.05 Mn
Dec 31, 2020 1.06 Mn
Sep 30, 2020 1.15 Mn
Jun 30, 2020 1.15 Mn
Mar 31, 2020 1.01 Mn
Dec 31, 2019 1.15 Mn
Sep 30, 2019 1.15 Mn
Jun 30, 2019 1.16 Mn
Mar 31, 2019 1.15 Mn
Dec 31, 2018 1.15 Mn
Sep 30, 2018 5.78 Mn
Jun 30, 2018 5.78 Mn
Mar 31, 2018 5.84 Mn
Dec 31, 2017 5.84 Mn
Sep 30, 2017 5.84 Mn
Jun 30, 2017 5.84 Mn
Mar 31, 2017 5.84 Mn
Dec 31, 2016 5.84 Mn
Sep 30, 2016 10.84 Mn
Jun 30, 2016 10.68 Mn
Mar 31, 2016 10.68 Mn
Dec 31, 2015 219,000.00
Sep 30, 2015 679,000.00
Jun 30, 2015 679,000.00
Mar 31, 2015 439,000.00
Dec 31, 2014 679,000.00
Sep 30, 2014 679,000.00
Jun 30, 2014 439,000.00
Mar 31, 2014 267,000.00
Dec 31, 2013 100,000.00
Sep 30, 2013 679,000.00
Jun 30, 2013 679,000.00
Mar 31, 2013 679,000.00
Dec 31, 2012 679,000.00
Sep 30, 2012 563,000.00
Jun 30, 2012 235,000.00
Mar 31, 2012 102,000.00
Dec 31, 2011 193,000.00
Sep 30, 2011 119,000.00
Jun 30, 2011 136,000.00
Dec 31, 2010 193,000.00